-
EP4019044
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4019044
| EP4019044 - STABILIZED VIRAL CLASS I FUSION PROTEINS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 07.07.2023 Database last updated on 24.07.2024 | |
| Former | Request for examination was made Status updated on 24.02.2023 | ||
| Former | The application has been published Status updated on 27.05.2022 | Most recent event Tooltip | 07.07.2023 | Application deemed to be withdrawn | published on 09.08.2023 [2023/32] | Applicant(s) | For all designated states Janssen Vaccines & Prevention B.V. Archimedesweg 4 2333 CN Leiden / NL | [2022/26] | Inventor(s) | 01 /
LANGEDIJK, Johannes, Petrus, Maria 2333 CN Leiden / NL | [2022/26] | Representative(s) | Manten, Annemieke, et al Janssen Vaccines & Prevention B.V. Archimedesweg 4-6 2333 CN Leiden / NL | [2022/26] | Application number, filing date | 21200796.7 | 01.09.2016 | [2022/26] | Priority number, date | US201562213466P | 02.09.2015 Original published format: US 201562213466 P | [2022/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4019044 | Date: | 29.06.2022 | Language: | EN | [2022/26] | Type: | A3 Search report | No.: | EP4019044 | Date: | 24.08.2022 | Language: | EN | [2022/34] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 22.07.2022 | Classification | IPC: | A61K39/12, A61K39/145, A61K39/21, C07K2/00 | [2022/26] | CPC: |
C07K14/005 (EP,US);
A61P31/12 (EP);
A61P31/14 (EP);
A61P31/16 (EP,US);
A61P31/18 (EP,US);
A61P31/22 (EP,US);
A61P37/04 (EP);
C12N2740/16022 (EP,US);
C12N2760/14122 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/13] |
| Former [2022/26] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | STABILISIERTE FUSIONSPROTEINE DER VIRUSKLASSE I | [2022/26] | English: | STABILIZED VIRAL CLASS I FUSION PROTEINS | [2022/26] | French: | PROTÉINES DE FUSION VIRALES STABILISÉES DE CLASSE I | [2022/26] | Examination procedure | 23.02.2023 | Examination requested [2023/13] | 23.02.2023 | Date on which the examining division has become responsible | 25.02.2023 | Application deemed to be withdrawn, date of legal effect [2023/32] | 21.03.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2023/32] | Parent application(s) Tooltip | EP16760463.6 / EP3344288 | Fees paid | Renewal fee | 04.10.2021 | Renewal fee patent year 03 | 04.10.2021 | Renewal fee patent year 04 | 04.10.2021 | Renewal fee patent year 05 | 04.10.2021 | Renewal fee patent year 06 | 16.08.2022 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2013079473 (CRUCELL HOLLAND BV [NL]) [A] 1,16-26 * the whole document *; | [Y]WO2014174018 (CRUCELL HOLLAND BV [NL]) [Y] 1-9,25,26 * Whole doc., in partic. example 2; Tables 7,9; p.9, l.1-3 *; | [X]EP2873423 (INT AIDS VACCINE INITIATIVE [US], et al) [X] 1,10-15,25,26 * Whole doc., in particular para. [0015]; Example 5; Fig.58; claim 23 *; | [E]EP3072901 (INT AIDS VACCINE INITIATIVE [US], et al) [E] 1,10-12,25,26 * Whole doc., in particular para. [0015, claim 2] *; | [XP] - KRARUP A ET AL, "A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism", NATURE COMMUNICATIONS, NATURE PUBLISHING GROUP, UNITED KINGDOM, vol. 6, doi:10.1038/NCOMMS9143, ISSN 2041-1723, (20150903), pages 8143 - 1, (20150903), XP002755858 [XP] 1-9,25,26 * Whole doc., in partic. section "Stabilizing the alpha4-alpha5 hinge loop"; discussion * DOI: http://dx.doi.org/10.1038/ncomms9143 | [Y] - SANDERS R W ET AL, "Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20020901), vol. 76, no. 17, doi:10.1128/JVI.76.17.8875-8889.2002, ISSN 0022-538X, pages 8875 - 8889, XP002393505 [Y] 1-9,25,26 * Whole doc., in partic. abstract; p.8876, col.1;Table 2; Fig.7 * DOI: http://dx.doi.org/10.1128/JVI.76.17.8875-8889.2002 | [I] - BEDDOWS SIMON ET AL, "Construction and characterization of soluble, cleaved, and stabilized trimeric Env proteins based on HIV type 1 Env subtype A", AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, US, (20060601), vol. 22, no. 6, ISSN 0889-2229, pages 569 - 579, XP009135800 [I] 1-9,25,26 * Whole doc., in partic. abstact; p.571 (Results) * | [I] - SINGH M ET AL, "LearnCoil-VMF: computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins", JOURNAL OF MOLECULAR BIOLOGY, ACADEMIC PRESS, UNITED KINGDOM, (19990730), vol. 290, no. 5, doi:10.1006/JMBI.1999.2796, ISSN 0022-2836, pages 1031 - 1041, XP004461983 [I] 1-9,25,26 * p.1035, col.2 * DOI: http://dx.doi.org/10.1006/jmbi.1999.2796 | [A] - CATHERINE L. HUNT ET AL, "Filovirus Entry: A Novelty in the Viral Fusion World", VIRUSES, (20120207), vol. 4, no. 12, doi:10.3390/v4020258, pages 258 - 275, XP055308711 [A] 1-9,25,26 * the whole document * DOI: http://dx.doi.org/10.3390/v4020258 | [A] - GOMARA M J ET AL, "Roles of a conserved proline in the internal fusion peptide of Ebola glycoprotein", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, (20040702), vol. 569, no. 1-3, doi:10.1016/J.FEBSLET.2004.06.006, ISSN 0014-5793, pages 261 - 266, XP004517496 [A] 1-9,25,26 * the whole document * DOI: http://dx.doi.org/10.1016/j.febslet.2004.06.006 | [XI] - MARIE PANCERA ET AL, "Structure and immune recognition of trimeric pre-fusion HIV-1 Env", NATURE, (20141008), vol. 514, no. 7523, doi:10.1038/nature13808, ISSN 0028-0836, pages 455 - 461, XP055178485 [X] 1,10,25,26 * the whole document * [I] 11-15 DOI: http://dx.doi.org/10.1038/nature13808 | [XI] - KANG Y ( ET AL, "Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 27, no. 37, ISSN 0264-410X, (20090813), pages 5120 - 5132, (20090628), XP026351749 [X] 1,10,25,26 * the whole document * [I] 11-15 | [XI] - HUI QIAO ET AL, "Specific Single or Double Proline Substitutions in the "Spring-loaded" Coiled-Coil Region of the Influenza Hemagglutinin Impair or Abolish Membrane Fusion Activity", THE JOURNAL OF CELL BIOLOGY, (19980615), vol. 141, no. 6, pages 1335 - 1347, XP055292514 [X] 1,19,25,26 * Whole doc., in particular Abstract; p.1338, col.1; Section "Fusion Activity"; p.1342, col.1. * [I] 16-18,20-24 DOI: http://dx.doi.org/10.1083/jcb.141.6.1335 | [XI] - J. A. GRUENKE ET AL, "New Insights into the Spring-Loaded Conformational Change of Influenza Virus Hemagglutinin", JOURNAL OF VIROLOGY., US, (20020501), vol. 76, no. 9, doi:10.1128/JVI.76.9.4456-4466.2002, ISSN 0022-538X, pages 4456 - 4466, XP055322806 [X] 1,9,25,26 * Whole doc., in particular Abstract; Fig.1; Discussion * [I] 16-18,20-24 DOI: http://dx.doi.org/10.1128/JVI.76.9.4456-4466.2002 | [A] - J TIMMINS, "Structural studies on the Ebola virus matrix protein VP40 indicate that matrix proteins of enveloped RNA viruses are analogues but not homologues", FEMS MICROBIOLOGY LETTERS, GB, (20040415), vol. 233, no. 2, doi:10.1016/j.femsle.2004.03.002, ISSN 0378-1097, pages 179 - 186, XP055323702 [A] 1-26 * the whole document * DOI: http://dx.doi.org/10.1016/j.femsle.2004.03.002 | by applicant | WO9003184 | WO9014837 | US5057540 | US5122458 | US5385839 | WO9609378 | WO9611711 | WO2004004762 | WO2005002620 | - EARP et al., Current topics in microbiology and immunology, (20050000), vol. 185, pages 26 - 66 | - JARDETZKY et al., Current opinion in virology, (20140000), vol. 5, pages 24 - 33 | - SANDERS et al., Journal of virology, (20020000), vol. 76, pages 8875 - 8889 | - PANCERA et al., Nature, (20140000), vol. 514, pages 455 - 461 | - KRARUP et al., Nature Communications, (20150000), page 8143 | - KWON et al., Nat Struct Mol Biol, (20150000), vol. 22, no. 7, pages 522 - 531 | - EGLEN et al., Curr Chem Genomics, (20080000), vol. 1, pages 2 - 10 | - DREYFUS, Science, (20120000), vol. 337, no. 6100, pages 1343 - 8 |